Results for tag: "Neurological Biomarker Immunoassay"

A neurological biomarker immunoassay is a type of biomarker used to measure the presence of a specific protein or other molecule in the body that is associated with a neurological disorder. These biomarkers are used to diagnose and monitor neurological diseases, such as Alzheimer's, Parkinson's, and multiple sclerosis. They can also be used to measure the effectiveness of treatments for these diseases. Neurological biomarker immunoassays are typically performed using a combination of immunoassay techniques, such as ELISA, Western blotting, and immunohistochemistry. The neurological biomarker immunoassay market is a rapidly growing segment of the biomarker industry. It is driven by the increasing prevalence of neurological diseases, as well as the need for more accurate and reliable diagnostic and monitoring tools. The market is expected to continue to grow as new technologies and techniques are developed to improve the accuracy and reliability of these tests. Some companies in the neurological biomarker immunoassay market include Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Abcam. Show Less Read more